Issue link: https://nebusinessmedia.uberflip.com/i/1463910
25 HARTFORDBUSINESS.COM | April 11, 2022 Largest bioscience/biotechnology companies in CT Ranked by number of employees as of October 2021 Largest bioscience/biotechnology companies in CT Ranked by number of employees as of October 2021 Rank Company No. CT employees/ No. worldwide employees Headquarters/ Headquarters/ Focus Ownership type/ Ticker Symbol Head of company/ Year founded 1 Pfizer Inc. 558 Eastern Point Road, Groton, CT 06340 (1) 860-441-4100 • www.pfizer.com 2,700 (2) 78,500 New York, NY Pharmaceutical research, development and manufacturing Public NYSE: PFE Albert Bourla CEO 1849 2 Boehringer Ingelheim Pharmaceuticals Inc. 900 Ridgebury Road, Ridgefield, CT 06877 203-798-9988 • boehringer-ingelheim.us 2,600 9,000 Ridgefield Development and manufacturer of human healthcare products especially in the areas of unmet medical need Private Jean-Michel Boers President, CEO, & managing director, Boehringer Ingelheim USA 1885 3 Medtronic Inc. 60 Middletown Ave., North Haven, CT 06473 203-492-5000 • www.medtronic.com 2,500 90,000 Dublin, Ireland Development, manufacturing and sales of surgical staplers Public NYSE: MDT Geoffrey S. Martha CEO 1949 4 Sema4 1 Commercial St., Branford, CT 06405 800-298-6470 • sema4.com 634 1,148 Stamford Patient-centered health intelligence leveraging AI and machine learning to derive data-driven insights Public NASDAQ: SMFR Eric Schadt Founder & CEO 2017 5 Alexion Pharmaceuticals Inc. (3) 100 College St., New Haven, CT 06510 475-230-2596 • alexion.com 500 3,800 Boston, MA Severe and life-threatening rare disorders Public NASDAQ: AZN Marc Dunoyer CEO, Alexion and CFO, AstraZeneca 1992 6 Jackson Laboratory for Genomic Medicine 10 Discovery Drive, Farmington, CT 06032 860-837-2474 • www.jax.org 450 2,626 Bar Harbor, ME Discovery of genomic causes of disease and development of diagnostics and therapeutics Non-profit Charles Lee Scientific director 2014 (4) 7 PerkinElmer Inc. 710 Bridgeport Ave., Shelton, CT 06484 (5) 203-925-4600 • www.perkinelmer.com 396 14,000 Waltham, MA Detection, imaging, informatics, software and services innovating for a healthier world Public NYSE: PKI Prahlad Singh CEO 1937 8 Hologic Inc. 36 Apple Ridge Road, Danbury, CT 06810 203-207-4500 • www.hologic.com 326 6,900 Marlborough, MA Diagnostic, medical imaging and surgical products for women's healthcare Public NASDAQ: HOLX Stephen P. MacMillan Chairman, president & CEO 1986 9 CooperSurgical Inc. (6) 75 Corporate Drive, Trumbull, CT 06611 203-601-5200 • www.coopersurgical.com 250 (7) 12,000 (8) Trumbull Development and commercialization of medical devices and diagnostics for women's health Public NYSE: COO (9) Holly Sheffield President 1990 10 Arvinas Inc. 5 Science Park, 395 Winchester Ave., New Haven, CT 06511 203-535-1456 • www.arvinas.com 216 216 New Haven Development of therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare disease Public NASDAQ: ARVN John Houston President & CEO 2013 11 MannKind Corporation 1 Casper St., Danbury, CT 06810 203-798-8000 • www.mannkindcorp.com 190 340 Westlake Village, CA Development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases Public NASDAQ: MNKD Michael Castagna CEO 1991 12 TOMZ Corp. 47 Episcopal Road, Berlin, CT 06037 860-829-0670 • www.tomz.com 180 190 Berlin Medical device manufacturer Private Tom Matulaniec President 1988 13 Biohaven Pharmaceutical Holding Co. 215 Church St., New Haven, CT 06510 203-404-0410 • biohavenpharma.com 100 900 New Haven Neuroscience Public NYSE: BHVN Vlad Coric CEO 2013 13 Protein Sciences, a division of Sanofi 1000 Research Parkway, Meriden, CT 06450 203-427-2403 • www.sanofi.com 100 100,000 (10) Paris, France Vaccine development and protein production Public NASDAQ: SNY (11) Paul Hudson CEO, Sanofi 1994 15 Quantum-Si Inc. 520 Old Whitfield St., Guilford, CT 06437 203-458-7100 • www.quantum-si.com 80 121 Guilford Life sciences; protein sequencing Public NASDAQ: QSI Jonathan Rothberg (12) interim CEO 2013 16 CARA Therapeutics 107 Elm St., 9th Floor, 4 Stamford Plaza, Stamford, CT 06902 203-406-3700 • www.caratherapeutics.com 59 82 Stamford Development of therapeutics to treat human diseases associated with pruritus Public NASDAQ: CARA Christopher Posner Director, president & CEO 2004 17 BioXcel Therapeutics 555 Long Wharf Drive, New Haven, CT 06511 475-238-6837 • bioxceltherapeutics.com 50 83 New Haven Use of artificial intelligence to develop medicines for neuroscience, immuno-oncology and other diseases Public NASDAQ: BTAI Vimal D. Mehta Founder & CEO 2017 18 BioSig Technologies Inc. 55 Greens Farms Road, Westport, CT 06880 203-409-5444 • www.biosig.com 49 Westport Bioelectronic medicine Public NASDAQ: BSGM Kenneth L. Londoner CEO 2009 19 Precipio Inc. 4 Science Park, 3rd Floor, New Haven, CT 06511 203-787-7888 • www.precipiodx.com 40 60 Omaha, NE Genetic testing Public NASDAQ: PRPO Ilan Danieli CEO 2017 20 Tangen Biosciences Inc. 20 Commercial St., Branford, CT 06405 203-433-4045 • tangenbiosciences.com 33 33 Branford Molecular diagnostics Private Richard C. Birkmeyer President & CEO 2013 21 Rallybio Corporation 234 Church St., Suite 1020, New Haven, CT 06510 203-859-3820 • rallybio.com 31 31 New Haven Identification and development of transformative therapies for patients with severe and rare disorders Public NASDAQ: RLYB Martin Mackay Co-founder & CEO 2018 22 Oxford Performance Materials Inc. 30 S. Satellite Road, South Windsor, CT 06074 860-698-9300 • www.oxfordpm.com 30 30 South Windsor Patient implant solutions as well as materials technology for other industries Private Scott DeFelice President & CEO 2000 Source: Each company via survey, website and/or press releases, annual 10-K reports to SEC and Labor Market Information database, Conn. Dept. of Labor. (1) With an additional Conn. site in New Haven. (2) Plus an additional 2,700 contractors assigned to CT sites. (3) A subsidiary of AstraZeneca. (4) Year founded for the Farmington site. The Jackson Laboratory was founded in 1929. (5) With an additional R&D operation in Branford. (6) A wholly owned subsidiary of The Cooper Companies. (7) Number of employees is 250-499 according to CT Department of Labor, Labor Market Information. (8) As of October 31, 2020 as reported to SEC, form 10-K. (9) For parent company, The Cooper Companies. (10) Greater than 100,000 worldwide, Sanofi. (11) For parent company Sanofi S.A. based in Paris, France. (12) As of Feb. 8, 2022, serves as interim CEO until permanent successor to prior CEO John Stark is named. -Compiled by Heide Martin, hmartin@nebusinessmedia.com The List